Showing results (61-70 of 881) with videos related to
Sort By:
Pageof 89
Therapeutic Advances in Psychopharmacology|July 31, 2020
The effect of COVID-19 on absolute neutrophil counts in patients taking clozapineSiobhan Gee, David TaylorJournal of Psychopharmacology (Oxford, England)|September 22, 2005
Establishing a dose-response relationship for oral risperidone in relapsed schizophreniaNiina Ezewuzie, David TaylorEmergency Medicine Australasia : EMA|June 15, 2005
Transthoracic electrical bioimpedance: a means of filling the void?Ogilvie Thom, David TaylorHandbook of Clinical Neurology|April 30, 2013
Problematic behavior in children with epilepsy: issues and managementDavid Taylor, Frank BesagDrugs & Aging|December 17, 2013
Adverse effects of clozapine in older patients: epidemiology, prevention and managementDelia Bishara, David TaylorTeaching and Learning in Medicine|June 11, 2016
Morbidity and Mortality Conference: Its Purpose Reclaimed and Grounded in TheoryAlexander Gregor, David TaylorThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 14, 2020
Canadian Pioneers of Amyotrophic Lateral Sclerosis: A Brief HistoryAndrew Eisen, David TaylorJournal of the Mechanical Behavior of Biomedical Materials|September 14, 2019
In vitro characterisation of the erosion of soft tissues by surgical meshDavid Taylor, Ellen BartonPsychopharmacology|August 7, 2019
Correction to: Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literatureLoren Bailey, David TaylorInternational Journal of Psychiatry in Clinical Practice|June 17, 2014
A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidanceShubhra MacE, David TaylorPageof 89